![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oakrum-pharma-and-ani-pharmaceuticals-announce-the-launch-of-betaine-anhydrous-powder-the-first-generic-version-of-cystadane-betaine-anhydrous-for-oral-solution--powder-including-180-days-of-exclusivity-301481968.html
https://www.prnewswire.com/news-releases/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenur-sprinkle-deferasirox-granules-301310888.html
https://www.prnewswire.com/news-releases/oakrum-pharma-and-aucta-pharma-announce-us-fda-approval-of-generic-version-of-jadenu-sprinkle-deferasirox-granules-301252585.html
http://www.globenewswire.com/news-release/2020/04/15/2016587/0/en/Oakrum-Pharma-Announces-the-Launch-of-Toxo-Total-Care-Patient-Services-Program-to-Support-Pyrimethamine-25mg-Tablets.html
https://www.ptcommunity.com/wire/oakrum-pharma-announces-launch-pyrimethamine-25mg-tablets-united-states
https://www.prnewswire.com/news-releases/oakrum-pharma-announces-the-launch-of-pyrimethamine-25mg-tablets-in-the-united-states-301021098.html
https://www.prnewswire.com/news-releases/oakrum-pharma-and-biophore-announce-product-development-and-commercialization-partnership-300835129.html
https://www.prnewswire.com/news-releases/oakrum-pharma-and-biophore-announce-product-development-and-commercialization-partnership-300835129.html#:~:text=Jagadeesh%20Rangisetty%2C%20CEO%20of%20Biophore,past%20three%20years%20and%20plans
https://www.prnewswire.com/news-releases/oakrum-pharma-and-biophore-announce-product-development-and-commercialization-partnership-300835129.html